Name Net increased
positions
Increased positions Reduced positions Return since
31 Mar ‘17
76
9 9 0 38.8%
77
9 14 5 63.2%
78
9 14 5 19.1%
KPTI icon
79
Karyopharm Therapeutics
KPTI
$117M
9 31 22 96.7%
80
9 12 3 22.2%
81
9 23 14 46.1%
82
8 23 15 9.26%
83
8 17 9 10.1%
84
8 10 2 99%
85
8 13 5 61.7%
IMDX
86
Insight Molecular Diagnostics
IMDX
$185M
8 10 2 94.6%
87
8 15 7 5.54%
88
8 19 11 24.8%
89
8 29 21 22.1%
90
8 51 43 98.6%
91
8 13 5 15.2%
92
8 13 5 70.9%
93
8 19 11 53.5%
94
8 20 12 84.3%
95
8 15 7 74.4%
96
7 59 52 78.8%
97
7 12 5 19%
98
7 7 0 33.2%
99
7 10 3 3.88%
100
7 15 8 95.7%